Shipra Gandhi

MD
Medical Oncology

Cancers Treated:

Breast

About Shipra Gandhi

Positions

Roswell Park Comprehensive Cancer Center

  • Assistant Professor of Oncology
  • Breast and Early Phase Clinical Trials, Department of Medicine

Background

Education and Training:

  • 2010 - MD - Lady Hardinge Medical College, Delhi, India

Residency:

  • 2012-2015 - Internal Medicine, State University of New York at Buffalo, Buffalo, NY

Fellowship:

  • 2015-2018 - Hematology-Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Board Certification:

  • Hematology and Oncology - American Board of Internal Medicine
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Learn More
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Learn More

Clinical Trials

Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
Learn More
Propranolol Hydrochloride and Pembrolizumab in Treating Patients With Stage IIIC-IV Melanoma That Cannot Be Removed by Surgery
Learn More
Immunotherapy for triple-negative breast cancer Women in Science: Shipra Gandhi, MD

Featured on Cancer Talk

Immunotherapy for triple-negative breast cancer
Women in Science: Shipra Gandhi, MD

Publications

Full Publications list on PubMed